Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butyrate Enemas for Digestive Disorders in VLBW Preterms
NCT01536483Phase 3Terminated
- Sponsor
- CHU de Nantes
- Start
- Feb 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium butyrate in feeding intolerance and Gastrointestinal Dysmotility (2 arms), sponsored by CHU de Nantes. Primary endpoint: Efficacy of colonic butyrate enemas in digestive maturation of preterms. Started Feb 2012; status: terminated.
02
Drugs
sodium butyrate
03
Conditions
feeding intoleranceGastrointestinal Dysmotility
Beyond the preview
Go deeper on NCT01536483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536483.